PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
09-Mar-2021 Organoids Market is projected to reach US$ 3,420.40 million by 2027 and to grow at a CAGR of 22.1% theinsightpartners
08-Mar-2021 Aravive Announces First Patient Dosed in Phase 1b/2 Clinical Trial of AVB-500 in Patients with Clear Cell Renal Cell Carcinoma Aravive
08-Mar-2021 Nicotine Patch OTC Product Industry Market Report-Development Trends, Opportunities and Competitive Landscape in 2020 ARC Report Stores
08-Mar-2021 Suture Anchor Devices Industry Market Report-Development Trends, Opportunities and Competitive Landscape in 2020 ARC Report Stores
08-Mar-2021 AARDEX and Schreiner MediPharm reinforce their collaboration to Enhance Medication Adherence Management AARDEX Group
05-Mar-2021 Clinerion and Medexprim join forces to combine clinical and imaging data for research. Clinerion Ltd.
04-Mar-2021 Just under 2 weeks until SMi’s 2nd Annual AI in Drug Delivery 2021, sponsored by CAS, Dassault Systèmes and Gero SMi Group
04-Mar-2021 Pharmaceutical Continuous Manufacturing Market Driven By Munson Machinery, Fette Compacting, Alexanderwerk, Hovioneen Aesica, Munson Machinery The Insight Partners
04-Mar-2021 Novadip Biosciences receives IND approval from the FDA for regenerative bone product NVD-003 Novadip Biosciences
03-Mar-2021 Cancer Research UK and Teon Therapeutics Advance New First-In-Class Cancer Drug Into Clinical Trial Cancer Research UK
03-Mar-2021 ISA Pharmaceuticals selects product candidate for clinical trial with first in class COVID-19 immunotherapy ISA Pharmaceuticals
03-Mar-2021 Tech trial saves 430 weeks of waiting time in January Limbic
02-Mar-2021 Pharma Jobs in Germany on PharmiWeb.jobs PharmiWeb
02-Mar-2021 Highlight Therapeutics and Pivotal work together on melanoma therapy and launch a Phase IIa trial to examine BO-112 efficacy and safety Highlight Therapeutics
02-Mar-2021 Tezepelumab is the first biologic to consistently and significantly reduce exacerbations in broad population of severe asthma patients AstraZeneca and Amgen
02-Mar-2021 Oncorena Receives Approval of First in Patient Trial with Orellanine as a Potential Breakthrough Therapy in Metastatic Renal Cancer Patients Oncorena
01-Mar-2021 LEXEO Therapeutics Announces License Agreement and Consolidation of Comprehensive Pre-clinical Data Package to Support Cardiac Friedreich's Ataxia Gene Therapy Program (LX2006) LEXEO Therapeutics
01-Mar-2021 Phesi Collaborates with Alfasigma on Digital Transformation Project for Clinical Development and Commercialization Phesi
26-Feb-2021 Novartis’ Kisqali® (ribociclib) receives NICE recommendation for routine funding as second-line treatment of hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative locally advanced or metastatic breast cancer Novartis
26-Feb-2021 Avance Clinical and Medidata Celebrate Strategic Partnership and In-house Expert Accreditation Milestones Avance Clinical